MetaADEDB 2.0 @ LMMD
Estradiol
(ZVVGLAMWAQMPDR-WVEWYJOQSA-N)
Structure
SMILES
Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C.Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C.O
Molecular Formula:
C36H50O5
Molecular Weight:
562.779
Log P:
7.1541
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
5
TPSA:
90.15
CAS Number(s):
35380-71-3
Synonym(s)
1.
Estradiol
2.
17 beta-Estradiol
3.
Estradiol-17 beta
4.
Oestradiol
5.
17 beta-Oestradiol
6.
Aerodiol
7.
Delestrogen
8.
Estrace
9.
Estraderm TTS
10.
Estradiol Anhydrous
11.
Estradiol Hemihydrate
12.
Estradiol Hemihydrate, (17 alpha)-Isomer
13.
Estradiol Monohydrate
14.
Estradiol Valerate
15.
Estradiol Valeriante
16.
Estradiol, (+-)-Isomer
17.
Estradiol, (-)-Isomer
18.
Estradiol, (16 alpha,17 alpha)-Isomer
19.
Estradiol, (16 alpha,17 beta)-Isomer
20.
Estradiol, (17-alpha)-Isomer
21.
Estradiol, (8 alpha,17 beta)-(+-)-Isomer
22.
Estradiol, (8 alpha,17 beta)-Isomer
23.
Estradiol, (9 beta,17 alpha)-Isomer
24.
Estradiol, (9 beta,17 beta)-Isomer
25.
Estradiol, Monosodium Salt
26.
Estradiol, Sodium Salt
27.
Estradiol-17 alpha
28.
Estradiol-17beta
29.
Ovocyclin
30.
Progynon-Depot
31.
Progynova
32.
Vivelle
33.
17 beta Estradiol
34.
17 beta Oestradiol
35.
Estradiol 17 alpha
36.
Estradiol 17 beta
37.
Estradiol 17beta
38.
Progynon Depot
External Link(s)
MeSHD004958
PubChem Compound154274
KEGGdr:D07918
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product adhesion issueFAERS: 15US FAERS
2Application site rashFAERS: 5US FAERS
3Drug ineffectiveFAERS: 5US FAERS
4Application site pruritusFAERS: 3US FAERS
5Product quality issueFAERS: 3US FAERS
6Application site erythemaFAERS: 2US FAERS
7Device material issueFAERS: 2US FAERS
8Wrong technique in product usage processFAERS: 2US FAERS
9Adverse eventFAERS: 1US FAERS
10AngerFAERS: 1US FAERS
11Application site erosionFAERS: 1US FAERS
12Application site exfoliationFAERS: 1US FAERS
13Application site reactionFAERS: 1US FAERS
14ArthralgiaFAERS: 1US FAERS
15Back PainFAERS: 1US FAERS
16CryingFAERS: 1US FAERS
17Device used for unapproved scheduleFAERS: 1US FAERS
18Drug administered at inappropriate siteFAERS: 1US FAERS
19Extra dose administeredFAERS: 1US FAERS
20Feeling abnormalFAERS: 1US FAERS
21Hormone level abnormalFAERS: 1US FAERS
22Inappropriate schedule of drug administrationFAERS: 1US FAERS
23Incorrect dose administered by productFAERS: 1US FAERS
24Mood swingsFAERS: 1US FAERS
25NervousnessFAERS: 1US FAERS
26Patient dissatisfaction with treatmentFAERS: 1US FAERS
27Product complaintFAERS: 1US FAERS
28Product physical consistency issueFAERS: 1US FAERS
29Product physical issueFAERS: 1US FAERS
30Skin ErosionFAERS: 1US FAERS
31Skin irritationFAERS: 1US FAERS
32Skin reactionFAERS: 1US FAERS
33UrticariaFAERS: 1US FAERS
34Vulvovaginal drynessFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120263

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.